权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Bi-directional regulation of chemokine receptor signaling

趋化因子受体信号传导的双向调节

基本信息

批准号：
10471999
负责人：
Adriano Marchese
金额：
$ 30.61万
依托单位：
MEDICAL COLLEGE OF WISCONSIN
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-01 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10471999
关键词：
A kinase anchoring protein Address Anatomy BLR1 gene Binding Proteins Biochemical CXCL12 gene CXCL13 gene CXCR4 Receptors Cancer Etiology Cancer cell line Cell membrane Cell physiology Cells Cervical Cessation of life Clinical Data Distant Family G-Protein-Coupled Receptors Growth Health Hela Cells Heterotrimeric GTP-Binding Proteins In Vitro Knowledge Ligands Ligation Link Malignant Neoplasms Malignant neoplasm of cervix uteri Mediating Neoplasm Metastasis Phorbol Esters Physiological Play Prognosis Protein Family Protein Isoforms Protein Kinase C Proteins Publishing Receptor Signaling Regulation Reporting Role Scaffolding Protein Serine Signal Pathway Signal Transduction Small Interfering RNA Specific qualifier value Tail Testing Time base biophysical techniques cancer cell cell motility chemokine receptor desensitization in vivo insight lymph nodes new therapeutic target novel protein activation protein complex receptor response therapeutic development trafficking tumor growth tumor progression

项目摘要

PROJECT SUMMARY Cervical cancer remains one of the leading causes of cancer-related deaths world-wide. A large body of evidence indicates that a sub-family of G protein-coupled receptors (GPCRs), known as chemokine receptors, are linked to progression of several cancers, including cervical cancer. Dysregulated signaling of certain chemokine receptors correlates with poor prognosis in cervical cancer, yet the mechanisms remain poorly understood. The overall objective of this proposal is to determine the mechanisms governing chemokine receptor regulation in the context of cervical cancer growth and metastasis. This is significant because these studies will define new targets for clinical potential. Specifically, we will focus on a novel paradigm that governs chemokine receptor bi-directional regulation by A kinase anchoring proteins (AKAPs). AKAPs are scaffolding proteins that bind and nucleate multiple proteins, usually belonging to a common signaling pathway, to spatially and temporally control signaling to drive physiological responses. We performed a siRNA screen of AKAPs expressed in HeLa cells, a cervical cancer cell line, and provide evidence that AKAPs are involved in cross- regulation of chemokine receptor trafficking. Further, using biochemical and biophysical approaches we provide evidence that chemokine receptors reside in a compartment with AKAPs and protein kinas C (PKC), but that other GPCRs are excluded. It is possible that chemokine receptors might co-reside in a sub- compartment at the plasma membrane that enables their cross-regulation without input from other GPCRs, likely to exclusively fine tune their signaling. Based on published and new preliminary data we hypothesize that chemokine receptors are part of a multimeric protein complex compartmentalized by AKAPs that governs their bi-directional regulation. To test this hypothesis we will pursue three specific aims. Aim 1: To determine the role of PKC in bi-directional chemokine receptor regulation; Aim 2: To determine the role of AKAPs in chemokine receptor bi-directional trafficking and signaling; and Aim 3: To determine the role of bi-directional chemokine receptor regulation in cervical cancer in vitro and in vivo. At the conclusion of the proposed studies we expect to determine the mechanism of bi-directional regulation of chemokine receptor signaling. Importantly, we expect to establish that novel aspects of chemokine receptor regulation and signaling could be targeted to treat cervical cancer.

项目总结